Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-30

Clinical Trial Update: Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care

View source ↗

Summary

This clinical trial entry notes ongoing recruitment for a study evaluating nasal nitric oxide testing to improve clinical care for Primary ciliary dyskinesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Arkansas Children's Hospital Research Institute | Conditions: Primary Ciliary Dyskinesia | Status: RECRUITING